122 related articles for article (PubMed ID: 15120171)
1. Cardiac phosphorus-31 two-dimensional chemical shift imaging in patients with hereditary hemochromatosis.
Schocke MF; Zoller H; Vogel W; Wolf C; Kremser C; Steinboeck P; Poelzl G; Pachinger O; Jaschke WR; Metzler B
Magn Reson Imaging; 2004 May; 22(4):515-21. PubMed ID: 15120171
[TBL] [Abstract][Full Text] [Related]
2. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
3. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
[TBL] [Abstract][Full Text] [Related]
4. Cardiac high-energy phosphate metabolism alters with age as studied in 196 healthy males with the help of 31-phosphorus 2-dimensional chemical shift imaging.
Esterhammer R; Klug G; Wolf C; Mayr A; Reinstadler S; Feistritzer HJ; Metzler B; Schocke MF
PLoS One; 2014; 9(6):e97368. PubMed ID: 24940736
[TBL] [Abstract][Full Text] [Related]
5. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors improve myocardial high-energy phosphate metabolism in men.
Schocke MF; Martinek M; Kremser C; Wolf C; Steinboeck P; Lechleitner M; Jaschke W; Pachinger O; Metzler B
J Cardiovasc Magn Reson; 2003; 5(4):595-602. PubMed ID: 14664137
[TBL] [Abstract][Full Text] [Related]
6. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
Byrnes V; Ryan E; O'Keane C; Crowe J
Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
[TBL] [Abstract][Full Text] [Related]
8. Impact of aging on cardiac high-energy phosphate metabolism determined by phosphorus-31 2-dimensional chemical shift imaging (31P 2D CSI).
Schocke MF; Metzler B; Wolf C; Steinboeck P; Kremser C; Pachinger O; Jaschke W; Lukas P
Magn Reson Imaging; 2003 Jun; 21(5):553-9. PubMed ID: 12878266
[TBL] [Abstract][Full Text] [Related]
9. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
10. Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis.
Fonseca PFS; Cançado RD; Naoum FA; Dinardo CL; Fonseca GHH; Gualandro SFM; Krieger JE; Pereira AC; Brissot P; Santos PCJL
BMC Med Genet; 2018 Jan; 19(1):3. PubMed ID: 29301508
[TBL] [Abstract][Full Text] [Related]
11. [Iron metabolism in hereditary hemochromatosis].
Andreeva AP; Levina AA; Sattarova DA; Tsibul'skaia MM; Tokarev iuN
Vrach Delo; 1989 Apr; (4):65-9. PubMed ID: 2756692
[TBL] [Abstract][Full Text] [Related]
12. Update on hereditary hemochromatosis and the HFE gene.
Brandhagen DJ; Fairbanks VF; Batts KP; Thibodeau SN
Mayo Clin Proc; 1999 Sep; 74(9):917-21. PubMed ID: 10488796
[TBL] [Abstract][Full Text] [Related]
13. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
14. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
15. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.
Casanova-Esteban P; Guiral N; Andrés E; Gonzalvo C; Mateo-Gallego R; Giraldo P; Paramo JA; Civeira F
Metabolism; 2011 Jun; 60(6):830-4. PubMed ID: 20846699
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
[TBL] [Abstract][Full Text] [Related]
17. A population-based study of the clinical expression of the hemochromatosis gene.
Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
[TBL] [Abstract][Full Text] [Related]
18. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
Kom GD; Schwedhelm E; Nielsen P; Böger RH
Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
[TBL] [Abstract][Full Text] [Related]
19. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
[TBL] [Abstract][Full Text] [Related]
20. Unsaturated iron binding capacity and transferrin saturation are equally reliable in detection of HFE hemochromatosis.
Murtagh LJ; Whiley M; Wilson S; Tran H; Bassett ML
Am J Gastroenterol; 2002 Aug; 97(8):2093-9. PubMed ID: 12190182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
